Click the link below to download the clinical study on Liposomal Glutathione absorption
A large Swedish study evaluated whether GLP-1 medicines are associated with a rare optic nerve condition causing sudden vision loss
The critical design decisions included: GIP backbone selection : Starting from GIP rather than GLP-1, as GIP naturally has weak cross-reactivity with GLP-1R, providing a scaffold for optimization Aib2 substitution : Replacing Ala2 with alpha-aminoisobutyric acid for DPP-4 resistance (identical strategy to semaglutide) C-terminal extension : Adding a GGPSSGAPPPS (Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser) 11-residue C-terminal extension that enhances GLP-1R binding C-20 fatty diacid acylation : Attaching an eicosanedioic acid (C-20 diacid) at Lys20 via a Glu-2xOEG linker for albumin binding The resulting molecule exhibits approximately 5:1 selectivity for GIPR over GLP-1R it is a full GIPR agonist and a partial GLP-1R agonist, yet clinically achieves superior outcomes to selective full GLP-1R agonists [7]
It uses sucrose , not aspartame, and can make more sense for people who want to mix psyllium into their own preferred routine
Ghrelin is the hormone responsible for making us feel hungry when other hormones like leptin are not blocking it
By combining advanced medical monitoring with lifestyle guidance, patients receive the tools they need for long-term success in achieving their health and weight goals
